4-(4-브로모페닐)-1,2,3-티아디아졸
|
|
4-(4-브로모페닐)-1,2,3-티아디아졸 속성
- 녹는점
- 154 °C
- 끓는 점
- 341.5±34.0 °C(Predicted)
- 밀도
- 1.642±0.06 g/cm3(Predicted)
- 산도 계수 (pKa)
- -4.38±0.27(Predicted)
안전
- 위험 및 안전 성명
- 위험 및 사전주의 사항 (GHS)
위험품 표기 | Xi,T | ||
---|---|---|---|
위험 카페고리 넘버 | 36/37/38-25 | ||
안전지침서 | 26-36/37/39-45-37/39 | ||
HS 번호 | 29349990 | ||
독성 | mouse,LD,intraperitoneal,> 1gm/kg (1000mg/kg),Pharmaceutical Chemistry Journal Vol. 28, Pg. 99, 1994. |
그림문자(GHS): | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
신호 어: | Warning | |||||||||||||||||||||||||||||||||||||||||||||||||
유해·위험 문구: |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
예방조치문구: |
|
4-(4-브로모페닐)-1,2,3-티아디아졸 C화학적 특성, 용도, 생산
화학적 성질
Light yellow solid4-(4-브로모페닐)-1,2,3-티아디아졸 준비 용품 및 원자재
원자재
준비 용품
4-(4-브로모페닐)-1,2,3-티아디아졸 공급 업체
글로벌( 26)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
CONIER CHEM AND PHARMA LIMITED | +8618523575427 |
sales@conier.com | China | 49392 | 58 |
Amadis Chemical Company Limited | 571-89925085 |
sales@amadischem.com | China | 131980 | 58 |
J & K SCIENTIFIC LTD. | 010-82848833 400-666-7788 |
jkinfo@jkchemical.com | China | 96815 | 76 |
Meryer (Shanghai) Chemical Technology Co., Ltd. | 021-61259108 18621169109 |
market03@meryer.com | China | 40240 | 62 |
Thermo Fisher Scientific | 800-810-5118 |
cnchemical@thermofisher.com | China | 17779 | 75 |
9ding chemical ( Shanghai) Limited | 4009209199 |
sales@9dingchem.com | China | 22519 | 55 |
Adobe Chem Co., Ltd. | 2332782371 |
adobechem@qq.com | China | 7980 | 58 |
Tianjin heowns Biochemical Technology Co., Ltd. | 400-638-7771 18920564737 |
sales@heowns.com | China | 20904 | 60 |
4-(4-브로모페닐)-1,2,3-티아디아졸 관련 검색:
4-(2-bromophenyl)-1,2,3-thiadiazole
(2S)-2,3-Dihydro-5-(methylthio)-3-[(2S)-2-hydroxy-2-phenylacetyl]-2-(4-bromophenyl)-1,3,4-thiadiazole
(2R)-2,3-Dihydro-5-(methylthio)-3-[(2S)-2-hydroxy-2-phenylacetyl]-2-(4-bromophenyl)-1,3,4-thiadiazole
(2R)-2,3-Dihydro-5-(methylthio)-3-[(2R)-2-hydroxy-2-phenylacetyl]-2-(4-bromophenyl)-1,3,4-thiadiazole
(2S)-2,3-Dihydro-5-(methylthio)-3-[(2S)-2-hydroxypropionyl]-2-(4-bromophenyl)-1,3,4-thiadiazole
N-(3-bromophenyl)-1,2,5-thiadiazole-3-carboxamide
2-Amino-5-(4-bromophenyl)-1,3,4-thiadiazole 97%,2-AMINO-5-(4-BROMOPHENYL)-1,3,4-THIADIAZOLE
ethyl 3-(2-bromophenyl)-1,2,4-thiadiazole-5-carboxylate
(2R)-2,3-Dihydro-5-(methylthio)-3-[(2S)-2-hydroxypropionyl]-2-(4-bromophenyl)-1,3,4-thiadiazole
(2S)-2,3-Dihydro-5-(methylthio)-3-[(2R)-2-hydroxy-2-phenylacetyl]-2-(4-bromophenyl)-1,3,4-thiadiazole
N-(4-BROMOPHENYL)-1,2,3-THIADIAZOLE-4-CARBOXAMIDE
ethyl 3-(4-bromophenyl)-1,2,4-thiadiazole-5-carboxylate
4-PHENYL-1,2,3-THIADIAZOLE
4-(4-BROMOPHENYL)-1,2,3-THIADIAZOLE
4-METHYL-1,2,3-THIADIAZOLE